U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734103) titled 'Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder' on June 03.
Brief Summary: The primary objective of this study is to evaluate the efficacy and tolerability of Lumateperone in reducing stuttering symptoms.
The following scales and samples will be collected for clinical and functional outcomes. * MLGSSS * SSS * Stuttering Severity Instrument (SSI-IV) * PHQ-9 * Barnes Akathisia * SAS * AIMS * CGI-I * CGI-S
Study Start Date: April 18
Study Type: INTERVENTIONAL
Condition:
Stuttering, Adult
Intervention:
DRUG: Lumateperone (ITI-007)
This medication is a tablet that is taken once daily
DRUG: Placebo ...